Deepflare
Deepflare predicts true T-cell immunogenicity with 12x greater accuracy than standard tools.
$2M Seed ·
Source: startupintros.com
Latest round on record: Pre Seed, July 2022, amount undisclosed.
All 2 rounds ↓Signals
About Deepflare
Design next-generation antigen candidates for vaccines and immunotherapies.
Deepflare | 1595 days on the record
Money raised, round by round (amounts linked to their source). Pins are dated signals; hover the icons for dates.
Funding rounds
- X account created
- Pre Seed · amount undisclosedSource: fundraisingfox.com
- Website created
- Seed · $2MSource: startupintros.com
Companies like Deepflare
GGleamer$29M Series B+ · Jun 2023
EEnara BioSeries B+ · Jun 2026
WWugen$35M Series B+ · Jul 2026OOblenio Bio$62M Series B+ · Jun 2026
EEpitopea$31M Series A · Oct 2024
GGrey Wolf Therapeutics$50M Series B+ · May 2024
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/deepflare (get a free API key).